AUM Biosciences and GLG are organising a panel discussion to exchange views about the emerging business models in drug development on May 14, 2019 in the GLG office, Singapore.

Location: GLG office, Singapore

Date & Time: 14 May, 2019 between 6.30 PM and 8.30 PM

Biotech companies commercialize new ideas and innovations through their business models. The same idea or innovation taken to market with different business models will yield different economic outcomes.

To discuss the various emerging business models in drug development, AUM Biosciences and GLG are organising a panel discussion with three industry experts.

The panel will also exchange views about the risks and opportunities involved in the future of drug development.

The speakers on the panel are:

  • Damian O’ Connell, CEO, Experimental drug development centre at A*Star
  • Vishal Doshi, Founder CEO, AUM Biosciences
  • Simranjit Singh, CEO, Asia, Middle-east and Africa, Guardant Health

For details about the event, contact: Yi Shun Tey | ytey@glggroup.com | +65 8614 8003

Note: The event is complimentary for all attendees.